Linking the epigenetic 'language' of covalent histone modifications to cancer

British Journal of Cancer

Volumn 90, Issue 4, 2004, Pages 761-769

  Hake, S B ^a   Xiao, A ^a   Allis, C D ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cancer; Chromatin; Epigenetics; Histones

Indexed keywords

ADENOSINE TRIPHOSPHATE; HISTONE;

ACETYLATION; CANCER GENETICS; CARCINOGENESIS; CHROMATIN; DNA METHYLATION; EPIGENETICS; GENETIC LINKAGE; PHOSPHORYLATION; PRIORITY JOURNAL; REVIEW; CELL TRANSFORMATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOPHYSIOLOGY;

ACETYLATION; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONES; HUMANS; NEOPLASMS; PHOSPHORYLATION;

EID: 1642358490     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601575     Document Type: Review

References (79)

1. Ahmad K, Henikoff S (2002) Histone H3 variants specify modes of chromatin assembly. Proc Natl Acad Sci USA 99(Suppl 4): 16477-16484
2. Ayton PM, Cleary ML (2001) Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20: 5695-5707
3. Ayton PM, Cleary ML (2003) Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 17: 2298-2307
4. Ayyanathan K, Lechner MS, Bell P, Maul GG, Schultz DC, Yamada Y, Tanaka K, Torigoe K, Rauscher III FJ (2003) Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: a mammalian cell culture model of gene variegation. Genes Dev 17: 1855-1869
5. Bachman KE, Park BH, Rhee I, Rajagopalan H, Herman JG, Baylin SB, Kinzler KW, Vogelstein B (2003) Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. Cancer cell 3: 89-95
6. Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33(Suppl): 238-244
7. Bannister AJ, Schneider R, Kouzarides T (2002) Histone methylation: dynamic or static? Cell 109: 801-806
8. Bassing CH, Suh H, Ferguson DO, Chua KF, Manis J, Eckersdorff M, Gleason M, Bronson R, Lee C, Alt FW (2003) Histone H2AX: a dosage-dependent suppressor of oncogenic translocations and tumors. Cell 114: 359-370
9. Beaudet AL (2002) Is medical genetics neglecting epigenetics? Genet Med 4: 399-402
10. Briggs SD, Bryk M, Strahl BD, Cheung WL, Davie JK, Dent SY, Winston F, Allis CD (2001) Histone H3 lysine 4 methylation is mediated by Set1 and required for cell growth and rDNA silencing in Saccharomyces cerevisiae. Genes Dev 15: 3286-3295
11. Brown R, Strathdee G (2002) Epigenomics and epigenetic therapy of cancer. Trends Mol Med 8: S43-S48
12. Celeste A, Difilippantonio S, Difilippantonio MJ, Fernandez-Capetillo O, Pilch DR, Sedelnikova OA, Eckhaus M, Ried T, Bonner WM, Nussenzweig A (2003) H2AX haploinsufficiency modifies genomic stability and tumor susceptibility. Cell 114: 371-383
13. Celeste A, Petersen S, Romanienko PJ, Fernandez-Capetillo O, Chen HT, Sedelnikova OA, Reina-San-Martin B, Coppola V, Meffre E, Difilippantonio MJ, Redon C, Pilch DR, Olaru A, Eckhaus M, Camerini-Otero RD, Tessarollo L, Livak F, Manova K, Bonner WM, Nussenzweig MC, Nussenzweig A (2002) Genomic instability in mice lacking histone H2AX. Science 296: 922-927
14. Chakraborty S, Senyuk V, Nucifora G (2001) Genetic lesions and perturbation of chromatin architecture: a road to cell transformation. J Cell Biochem 82: 310-325
15. Cheung P, Tanner KG, Cheung WL, Sassone-Corsi P, Denu JM, Allis CD (2000) Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 5: 905-915
16. Dahiya A, Wong S, Gonzalo S, Gavin M, Dean DC (2001) Linking the Rb and polycomb pathways. Mol Cell 8: 557-569
17. Das BR (1993) Increased ADP-ribosylation of histones in oral cancer. Cancer Lett 73: 29-34
18. Davie JK, Dent SY (2002) Transcriptional control: an activating role for arginine methylation. Curr Biol 12: R59-R61
19. Debernardi S, Bassini A, Jones LK, Chaplin T, Linder B, de Bruijn DR, Meese E, Young BD (2002) The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood 99: 275-281
20. Downs JA, Jackson SP (2003) Cancer: protective packaging for DNA. Nature 424: 732-734
21. Dunn BK (2003) Hypomethylation: one side of a larger picture. Ann N Y Acad Sci 983: 28-42
22. Ernst P, Wang J, Korsmeyer SJ (2002) The role of MLL in hematopoiesis and leukemia. Curr Opin Hematol 9: 282-287
23. Esteller M (2003) Relevance of DNA methylation in the management of cancer. Lancet Oncol 4: 351-358
24. Fair K, Anderson M, Bulanova E, Mi H, Tropschug M, Diaz MO (2001) Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Mol Cell Biol 21: 3589-3597
25. Felsenfeld G, Groudine M (2003) Controlling the double helix. Nature 421: 448-453
26. Fischle W, Wang J, Allis CD (2003a) Binary switches and modification cassettes - novel concepts in histone biology and beyond. Nature 425: 475-479
27. Fischle W, Wang Y, Allis CD (2003b) Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172-183
28. Fischle W, Wang Y, Jacobs SA, Kim Y, Allis CD, Khorasanizadeh S (2003c) Molecular basis for the discrimination of repressive methyl-lysine marks in histone H3 by Polycomb and HP1 chromodomains. Genes Dev 17: 1870-1881
29. Grewal SI, Moazed D (2003) Heterochromatin and epigenetic control of gene expression. Science 301: 798-802
30. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70
31. Harbour JW, Dean DC (2000) The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 14: 2393-2409
32. Hashimshony T, Zhang J, Keshet I, Bustin M, Cedar H (2003) The role of DNA methylation in setting up chromatin structure during development. Nat Genet 34: 187-192
33. Huang S (2002) Histone methyltransferases, diet nutrients and tumour suppressors. Nat Rev Cancer 2: 469-476
34. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl): 245-254
35. Javed A, Guo B, Hiebert S, Choi JY, Green J, Zhao SC, Osborne MA, Stifani S, Stein JL, Lian JB, van Wijnen AJ, Stein GS (2000) Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/ PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci 113(Part 12): 2221-2231
36. Jenuwein T, Allis CD (2001) Translating the histone code. Science 293: 1074-1080
37. Jones LK, Saha V (2002) Chromatin modification, leukaemia and implications for therapy. Br J Haematol 118: 714-727
38. Klochendler-Yeivin A, Yaniv M (2001) Chromatin modifiers and tumor suppression. Biochim Biophys Acta 1551: M1-M10
39. Krumlauf R (1994) Hox genes in vertebrate development. Cell 78: 191-201
40. Kurdistani SK, Grunstein M (2003) Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol 4: 276-284
41. Lachner M (2002) Epigenetics: SUPERMAN dresses up. Curr Biol 12: R434-R436
42. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266
43. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, Peters AH (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13: 1192-1200
44. Lo Coco F, Zelent A, Kimchi A, Carducci M, Gore SD, Waxman S (2002) Progress in differentiation induction as a treatment for acute promye-locytic leukemia and beyond. Cancer Res 62: 5618-5621
45. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260
46. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D, Brock HW, Slany R, Hess JL (2003) Dimerization of MLL fusion proteins immortalizes hematopoetic cells. Cancer Cell 4: 197-207
47. Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD, Hess JL (2002) MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell 10: 1107-1117
48. Min J, Zhang X, Cheng X, Grewal SI, Xu RM (2002) Structure of the SET domain histone lysine methyltransferase Clr4. Nat Struct Biol 9: 828-832
49. Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C (2003) ATP-driven exchange of histone HZAZ variant catalyzed by SWR1 chromatin remodeling complex. Science 16: 343-348
50. Monni O, Knuutila S (2001) 11q deletions in hematological malignancies. Leuk Lymphoma 40: 259-266
51. Muchardt C, Yaniv M (1999) ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job. J Mol Biol 293: 187-198
52. Muchardt C, Yaniv M (2001) When the SWI/SNF complex remodels ... the cell cycle. Oncogene 20: 3067-3075
53. Nie Z, Yan Z, Chen EH, Sechi S, Ling C, Zhou S, Xue Y, Yang D, Murray D, Kanakubo E, Cleary ML, Wang W (2003) Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage leukemia chromosomal translocation partner. Mol Cell Biol 23: 2942-2952
54. Nielsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T (2001) Rb targets histone H3 methylation and HP1 to promoters. Nature 412: 561-565
55. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM (2000) A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10: 886-895
56. Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W (2002) Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 12: 162-169
57. Rice JC, Allis CD (2001) Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr Opin Cell Biol 13: 263-273
58. Rozenblatt-Rosen O, Rozovskaia T, Burakov D, Sedkov Y, Tillib S, Blechman J, Nakamura T, Croce CM, Mazo A, Canaani E (1998) The C-terminal SET domains of ALL-1 and TRITHORAX interact with the INI1 and SNR1 proteins, components of the SWI/SNF complex. Proc Natl Acad Sci USA 95: 4152-4157
59. Schneider R, Bannister AJ, Kouzarides T (2002) Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 27: 396-402
60. Schreiber SL, Bernstein BE (2002) Signaling network model of chromatin. Cell 111: 771-778
61. Sellers WR, Loda M (2002) The EZH2 polycomb transcriptional repressor - a marker or mover of metastatic prostate cancer? Cancer Cell 2: 349-350
62. Sevenet N, Lellouch-Tubiana A, Schofield D, Hoang-Xuan K, Gessler M, Birnbaum D, Jeanpierre C, Jouvet A, Delattre O (1999) Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Hum Mol Genet 8: 2359-2368
63. Shao Z, Raible F, Mollaaghababa R, Guyon JR, Wu CT, Bender W, Kingston RE (1999) Stabilization of chromatin structure by PRC1, a Polycomb complex. Cell 98: 37-46
64. Snowden AW, Gregory PD, Case CC, Pabo CO (2002) Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo. Curr Biol 12: 2159-2166
65. So CW, Lin M, Ayton PM, Chen EH, Cleary ML (2003) Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias. Cancer Cell 4: 99-110
66. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ (1997) MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13 3). Proc Natl Acad Sci USA 94: 8732-8737
67. Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, Roy DC, Busque L, Kurnit D, Willman C, Gewirtz AM, Speck NA, Bushweller JH, Li FP, Gardiner K, Poncz M, Maris JM, Gilliland DG (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23: 166-175
68. Stallcup MR (2001) Role of protein methylation in chromatin remodeling and transcriptional regulation. Oncogene 20: 3014-3020
69. Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403: 41-45
70. Su IH, Basavaraj A, Krutchinsky AN, Hobert O, Ullrich A, Chait BT, Tarakhovsky A (2003) Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol 4: 124-131
71. Szyf M (2003) Targeting DNA methylation in cancer. Ageing Res Rev 2: 299-328
72. Tomonaga T, Matsushita K, Yamaguchi S, Oohashi T, Shimada H, Ochiai T, Yoda K, Nomura F (2003) Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer Res 63: 3511-3516
73. Turner BM (2000) Histone acetylation and an epigenetic code. BioEssays 22: 836-845
74. van Leeuwen F, Gottschling DE (2003) The histone minority report: the variant shall not be silenced. Cell 112: 591-593
75. Varambally S, Dhanasekaran SM, Zhou M, Barrette TR, Kumar-Sinha C, Sanda MG, Ghosh D, Pienta KJ, Sewalt RG, Otte AP, Rubin MA, Chinnaiyan AM (2002) The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419: 624-629
76. Wolffe AP, Kurumizaka H (1998) The nucleosome: a powerful regulator of transcription. Prog Nucleic Acid Res Mol Biol 61: 379-422
77. Xia ZB, Anderson M, Diaz MO, Zeleznik-Le NJ (2003) MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc Natl Acad Sci USA 100: 8342-8347
78. Zeitlin SG, Shelby RD, Sullivan KF (2001) CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J Cell Biol 155: 1147-1157
79. Zhang Y, Reinberg D (2001) Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev 15: 2343-2360